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Abstract
Background: Decompressive hemicraniectomy is a life-saving procedure for patients with malignant middle
cerebral artery infarctions. However, the neuropsychological sequelae in such patients have up to now received
little attention. In this study we not only describe neuropsychological deficits but also the quality of life and the
extent of depression and other psychiatric symptoms in patients after complete media infarction of the non-
speech dominant hemisphere.
Methods: 20 patients from two different university hospitals (mean ± standard deviation: 52 ± 14 years of age)
who had undergone hemicraniectomy with duraplasty above the non-speech dominant hemisphere at least one
year previously were examined using a thorough neurological and neuropsychological work-up. The quality of life
and the extent of psychiatric problems were determined on the basis of self-estimation questionnaires. The
patients were asked whether they would again opt for the surgical treatment when considering their own
outcome. 20 healthy persons matched for age, gender and education served as a control group.
Results: All patients but one were neurologically handicapped, half of them severely. Age was significantly
correlated with poorer values on the Rankin scale and Barthel index. All cognitive domain z values were
significantly lower than in the control group. Upon re-examination, 18 of 20 patients were found to be cognitively
impaired to a degree that fulfilled the formal DSM IV criteria for dementia.
Conclusions: Patients with non-speech dominant hemispheric infarctions and decompressive hemicraniectomy are
at high risk of depression and severe cognitive impairment.
Background
For more than a century, trephining of the skull to
relieve intracranial pressure due to brain swelling has
been a treatment option for space-occupying lesions
such as large brain infarctions in the area supplied by
the middle cerebral artery (MCA) [1]. With modern
intensive care, the mortality rate dropped to 70% [2],
and decompressive hemicraniectomy (DCH) has
reversed the ratio of survival and death as compared to
a conservative treatment regime alone. Further studies
showed improved survival rate with DCH and better
functional outcome [3-5]. Other authors have investi-
gated the quality of life (QoL) after extensive MCA
infarction [6,7] but to our knowledge only Leonhardt et
al. [8] sufficiently described neuropsychological pro-
blems in patients after DCH (n = 14). The majority of
their patients showed unexpectedly good results in some
cognitive areas. However, they examined memory
impairment only by one single subtest for non-verbal
memory. Memory functions are crucial for social func-
tioning, which is why memory impairment is an essen-
tial indicator of dementia. The primary aim of this study
was to examine cognitive functions after DCH. We also
described neurocognitive functions in DCH patients and
correlated them with the assessment of QoL and the
severity of mental symptoms.
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Patients
Between 2004 and 2008, we contacted patients who had
suffered from malignant infarction of the MCA and had
been treated using DCH with duraplasty at a university
medical center (Göttingen, Germany) between 1999 and
2003. A total of 58 patients were admitted to the Göt-
tingen university clinic for malignant MCA infarctions
during this time. In 1999, there were 18 patients, all of
whom had been treated conservatively. Between 2000
and 2003, 40 patients with malignant MCA infarction
were admitted, 19 of whom had been trephined and 21
treated conservatively. From 2000 on, patients with
malignant MCA infarctions were also treated using
DCH. All operated patients had infarctions of the non-
speech dominant hemisphere. Seventeen of the operated
patients could be re-examined; only one patient could
not be located. Of the 39 conservatively treated patients,
18 died while still hospitalized. Seven of the conserva-
tively treated patients could not be found for re-exami-
nation. In addition, we examined the 11 surviving
patients with non-speech dominant hemispheric infarc-
tions of the Jena University Hospital who comprised the
patient population reported by S. Harscher [3] and who
were operated on between 1996 and 2002. Three of
these patients agreed to neuropsychological re-
examination.
A prerequisite for inclusion in the study was that
DCH had been performed at least one year before re-
examination to allow for sufficient rehabilitation. All
patients had infarctions of the non-speech dominant
hemisphere (one was left-handed with a left-sided MCA
infarction and intact speech ability). A control group of
persons matched for age, gender and level of education
was used since no normal values have been established
for the extensive sequence of neuropsychological tests.
The only normal values available for the tests used here
are provided by handbooks for each single test. Exclu-
sion criteria for the control group were the presence of
neurological or psychiatric diseases, including substance
abuse. The study was approved by the ethics committee
o ft h eU n i v e r s i t yM e d i c a lCenter Göttingen (approval
no. 21102). The study was carried out in compliance
with the Helsinki Declaration. All patients or their legal
representatives gave informed consent before taking part
in the study.
Functional outcome
Patients were grouped according to the rating of their
activities of daily life (ADL) using measurements estab-
lished in stroke research [9-11], i.e. the Barthel index
(BI) [12], and the Nottingham extended activities of
daily living scale (NEADL) [13,14] (e.g.). Whether a cog-
nitive disturbance meets the criteria for dementia is also
dependent on the presence of impairment of the indivi-
dual’s social life and activities of daily living. Therefore,
we used a subscore composed of the five items from the
NEADL score ("NEADLred.“), all of which we considered
to be the most independent of concomitant physical
handicap ("write letters”, “make phone calls”, “read
books/newspapers”, “money management”, “social con-
tacts”). Clinical outcome was assessed using the NIH
stroke scale [15] (NIHSS).
Neuropsychological assessment
Alertness was examined using the computerized TAP
procedure [16], visual constructive functions were deter-
mined by a Rey-figure [17], verbal learning and memory
were tested using the verbal learning test (VLT) [18],
Wechsler memory scale (WMS-R) logical memory [19],
WMS-R verbal pairs [19], and the German translation
of the California verbal learning test (CVLT) [20].
Assessment of working memory was performed with the
W M SI I Id i g i ts p a nt e s ta n ds p a t i a ls p a nt e s t[ 2 1 ] .
Impairments of non-verbal learning and memory were
evaluated by the non-verbal learning test (NVLT) [22],
WMS-R visual pairs [21], and the City map test [23].
We examined the frontal executive functions with the
“Regensburger verbal fluency test with semantic altera-
tions” [24], the Wisconsin card sorting test [25], Ruff’s
test [26] and the test for similarities (part of Hamburg-
Wechsler Intelligence test for adults (HAWIE-R) [27]).
The “Aachener Aphasie Test” (AAT) token test [28] was
chosen to examine language impairment. All tasks in
each test were presented and performed in the person’s
h e a l t h yf i e l do fv i s i o n ,t or u l eo u ta n ye r r o rd u et o
hemianopsia. Because of the extent of the test battery
and the awareness that the handicapped patients might
have problems with their attention functions, we placed
the examinations of the domain attention in the early
phase of the test sequence.
Health related quality of Life (hrQoL)
The German version of the WHOQoL-Bref [29], a self-
rated questionnaire, was used to measure the quality of
life. In addition, the quality of sleep was measured using
the Pittsburgh quality of sleep questionnaire (PSQI) [30].
Grading of cognitive impairment
To evaluate the result of an entire neuropsychological
domain we determined whether subtests were impaired,
i.e. whether the z value was below -1.0 and thus below
the first standard deviation under the mean of the nor-
mative data [31]. In addition, domains consisting of just
one subtest (in this test battery, the domains of language
and visuo-constructive functions) were considered to be
impaired if the z values were lower than -2.0 [32]. There
are various definitions for post-stroke dementia. In our
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social factors and daily life activities (which we quanti-
fied using the NEADLred.), the DSM IV criteria require
memory impairment and at least one further impaired
domain.
In accordance with the literature, impaired memory
was diagnosed if the patient’s CVLT long delay, free
recall test yielded a z value of less than -1 [34]. None of
the patients had suffered from dementia or socially rele-
vant cognitive decline before the hemispheric stroke
occurred.
Psychological symptom load
The reduced symptom checklist 90 [35] (SCL90r) was
applied as a self-rating questionnaire for the evaluation
of the psychological symptom load, comprising the sub-
scales “somatization”, “obsessive compulsive”, “interper-
sonal sensitivity”, “ depression”, “anxiety”, “hostility”,
“phobic anxiety”, “paranoid ideation”,a n d“psychoti-
cism”. The evaluation yielded the global index measures
“global severity index (GSI)”, designed to measure over-
all psychological distress, the “positive symptom distress
index (PSDI)”, which measures the intensity of symp-
toms, and the “positive symptom total (PST)” that gives
the number of self-reported symptoms. The degree of
depression was quantified in addition to SCL90r scale 4
(depression) with the Beck’s depression inventory (BDI)
[36].
Statistics
Data are given as mean and standard deviation, and cog-
nitive data also include a 5-95% confidence interval
(table 1). The Whitney-Mann U rank sum test was
applied for group comparisons whenever Gaussian dis-
tribution was not present; otherwise, a t-test for inde-
pendent samples was used. Spearman’s r was calculated
to analyze correlations. Frequencies were compared
using Fishers’s exact test in four-field tables unless more
than four fields were present; in this case, the Chi
2-test
was calculated.
Results
Patients and control group
The patient group (P) and the group of 20 healthy con-
trol persons (C) were matched for age (mean ± SD 55.5
± 13.7P vs. 53.5 ± 13.0 yearsC; p = 0.65), sex (m/w 16/4P
vs. 15/5C, p = 1) and education (9.9 ± 1.6P vs. 10.4 ±
2.3C school years, p = 0.4). The age at neuropsychologi-
cal examination was 55.4P ± 13.7 and 53.5C ± 13.0
years, respectively (p = 0.65). In the group of patients
the mean interval from the first symptoms to DCH was
45.8 ± 60 hours (median [25
th/75
th] 21.8 [15.6/52.5]).
Eleven of the patients had undergone DCH in the early
course (< 24 h after onset of symptoms) and in 9
patients, DCH had been delayed.
Re-examination of patients was carried out at a mean
±S D3 . 0±0 . 8( m e d i a n[ 2 5
th/75
th] 2.4 [1.7/3.5]) years
later.
In agreement with the literature, the patients in this
collective with malignant MCA infarction survived sig-
nificantly more often with neurosurgical than with con-
servative treatment (18 of 19 vs. 21 of 39 hospital
survivors, p = 0.0014). Upon re-examination of the
patients who received DCH, 17 patients lived at home;
three were living in a nursing home. Nine of 20 patients
had developed symptomatic epilepsy, and 13 had been
diagnosed with post-stroke depression; 11 of them were
treated at the time of examination with anti-depressive
agents. Confronted with the hypothetical situation of
turning back time to the decision to undergo DCH, the
majority of patients stated that they would again opt for
a decompressive hemicraniectomy (13 “yes” vs. 7 “no";
Table 1). This statement was independent of the pre-
sence of cognitive impairment (Fisher’se x a c tt e s tp=
0.58).
Neurological outcome
At the time of re-examination the median [25
th/75
th
percentile] of the NIHSS was 10 [8.5/14] and 11 patients
had scale values of ≥ 10. Ten of 19 patients showed a
Barthel index greater than 50 (one patient with bilateral
leg amputation before the stroke occurred was
excluded), and the median [25
th/75
th percentile] was
46.5 [17.5/76.5]. The median modified Rankin scale was
4 (3.5/4.0; 25
th/75
th percentile), and 5 patients had a
mRS < 4 while 15 patients were affected severely (mRS
4 and 5).
The majority (16 patients) was mobile in their respec-
tive home settings, but only two displayed normal
ambulation.
Neuropsychological outcome
Four of 20 patients left out some tasks of the test bat-
tery, more than in the healthy control group (0/20). The
results of all subtests are summarized in Table 2. For all
subtests, the results of the patient group were signifi-
cantly worse than those of the control persons (Table
1). The mean ± SD z values of the respective domains
are given in Figure 1. No subject of the control group
fulfilled the criteria of abnormal cognitive functions.
The differences in cognitive functioning between
patients with and those without depression or epilepsy
were not significant. Eighteen of 20 patients fulfilled the
formal criteria for dementia according to the DSM IV;
one of them demonstrated abnormal cognitive perfor-
mance but only a slightly reduced NEADL and a normal
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derline case with only minimal cognitive impairment).
Even with a very conservative definition of neuropsy-
chological impairment (z < -1.5), 16 of 20 patients still
met the definition of dementia in accordance with
DSM IV.
Influence of age
Age correlated significantly negative with the BI (r =
-0.58; p = 0.007) and with a higher mRS (0.49; p =
0.03). Visuo-constructive functions (r = -0.51; p = 0.02)
and the physical quality of life in the WHOQoL-Bref
questionnaire (r = -0.59; p = 0.006) were correlated
negatively with the patients’ age at admission, whereas
the subjective physical quality of life was not correlated
with age (r = 0.05; p = 0.8). There was also no correla-
tion between the age at admission and the time interval
between stroke onset and surgery.
Glasgow Coma Scale (GCS) upon admission
Lower GCS at the time of admission was significantly
correlated with higher scores in the PSQI, i.e. with
poorer sleep quality after convalescence. We could not
find any further associations.
School years
The years of basic education were positively correlated
for subscales indicative of verbal learning (CVLT trial 5,
sum 1-5, slope), with subtests associated with frontal
executive functions (CVLT cluster, TAP go-no-go) and
also with the z value of domain values for attention and
verbal memory.
Psychological sequelae
The mental symptom load for all domains analyzed by
SCL90r was higher in patients compared with healthy
controls. These differences reached statistical significance
Table 1 Clinical and demographic data
Pt.
#
Sex Handed-
ness
Age at
admission
[years]
Affected
territory
EarlyDCM Stroke to
follow-up
[years]
Housing
situation
Returned
to work?
Ambu-
lation*
Epi-
lepsy
BI mod.
RS
NIHSS NEADL NEADL
red.°
Repeat
DCM?
1 f right 51,2 MCA,
PCA
yes 1.5 at home no 1 no 53 4 34 42 16 yes
2 m right 49,7 MCA yes 2.2 nursing
home
no 1 no 42 4 14 38 15 no
3 m both 61,3 MCA no 2.4 at home no 1 no 74 3 2 55 17 yes
4 m right 38,8 MCA no 2.1 at home no 1 yes 83 3 10 16 13 yes
5 m right 68,0 MCA,
ACA
no 3.0 at home n.a. 2 no 24 4 9 31 8 yes
6 f right 66,9 MCA yes 1.7 at home n.a. 4 no 10 4 15 26 7 no
7 m right 35,7 MCA,
ACA
no 4.1 at home no 1 no 76 3 8 31 16 yes
8 m right 69,7 MCA,
ACA
no 0.8 at home n.a. 4 no 6 5 18 23 5 yes
9 m right 66,9 MCA yes 1.5 at home n.a. 4 yes 22 4 10 34 14 yes
10 m right 46,7 MCA yes 1.7 at home no 0 yes 80 4 9 56 18 yes
11 f right 13,8 MCA,
ACA
no 2.9 at home yes 0 no 96 3 6 77 19 yes
12 m left 45,9 MCA yes 2.5 nursing
home
no 3 yes 77 4 13 30 10 no
13 f right 49,5 MCA no 2.9 at home no 1 no 95 0 5 42 16 yes
14 m right 45,1 MCA yes 2.9 at home no 1 yes 51 4 11 37 13 yes
15 m right 46,0 MCA no 6.1 at home no 1 no 40 4 15 85 20 no
16 m right 51,8 MCA no 7.9 nursing
home
no 4 no 10 5 7 33 10 no
17 m right 60,8 MCA yes 4.7 at home no 1 yes 39 4 10 39 15 yes
18 m both 45,5 MCA yes 5.0 at home no 1 yes 3 4 14 28 7 yes
19 m right 74,0 MCA yes 1.5 at home n.a. 3 yes 13 4 9 32 6 no
20 m right 63,7 MCA yes 1.9 at home no 3 yes 60 4 9 46 15 no
* Coding for ambulation: 0 = normal or slightly impaired, 1 = significantly impaired, 2 = independent only for a short distance, 3 = manages short distance only with
help, 4 = immobile
NEADL subscale with items that are independent from physical handicap (maximum 20 points)
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Stroke group Control group
z-values valid N mean ± SD CI [5% - 95%] valid N mean ± SD CI [5% - 95%] p-value
CVLT trial 1 20 -1.1 ± 1.2 [1.6 - -0.5] 20 -0.2 ± 1.0 [-0.6 - 0.3] 0.0056
CVLT trial 5 20 -2.2 ± 1.1 [-2.7 - -1.7] 20 0.2 ± 1.4 [-0.4 - 0.8] < 0.0001
CVLT sum 1-5 19 -2.0 ± 1.1 [-2.5 - -1.5] 20 0.1 ± 0.3 [-0.1 - 0.2] 0.0001
CVLT list B 20 -1.6 ± 1.2 [-2.1 - -1.0] 20 -0.5 ± 1.4 [-1.2 - 0.2] 0.0144
CVLT short delay free recall 20 -1.8 ± 1.1 [-2.3 - -1.2] 20 0.0 ± 1.0 [-0.4 - 0.5] 0.0001
CVLT short delay cued recall 20 -1.6 ± 1.3 [-2.1 - -1.0] 20 0.0 ± 1.2 [-0.5 - 0.5] 0.0007
CVLT long delay free recall 20 -1.5 ± 1.3 [-2.1 - -0.9] 20 0.3 ± 1.2 [-0.2 - 0.8] 0.0003
CVLT long delay cued recall 20 -1.5 ± 1.2 [-2.1 - -0.9] 20 0.2 ± 1.0 [-0.2 - 0.6] 0.0001
CVLT semantic cluster ratio 19 -1.4 ± 1.2 [-2.0 - -0.9] 20 -0.3 ± 1.3 [-0.9 - 0.3] 0.0070
CVLT serial cluster ratio 20 1.9 ± 1.4 [1.2 - 2.6] 20 0.5 ± 1.2 [-0.1 - 1.1] 0.0047
CVLT slope 20 -1.1 ± 1.0 [-1.6 - -0.6] 20 0.2 ± 1.1 [-0.3 - 0.7] 0.0014
CVLT perseverations 20 0.6 ± 0.9 [0.1 - 1.0] 20 0.6 ± 0.8 [0.2 - 0.9] 0.8181
CVLT recognition hits 20 -1.1 ± 1.1 [-1.6 - -0.5] 20 0.0 ± 1.1 [-0.6 - 0.5] 0.0077
CVLT false positive 20 -1.0 ± 1.3 [-1.6 - -0.4] 20 0.1 ± 0.3 [0.0 - 0.2] 0.0071
TAP alertness w/o audio alert; median reaction time 18 -2.2 ± 0.9 [-2.6 - -1.7] 20 -0.2 ± 0.8 [-0.6 - 0.1] < 0.0001
TAP alertness w/o audio alert; reaction time SD 18 -1.7 ± 1.3 [-2.3 - -1.1] 20 0.5 ± 1.5 [-0.2 - 1.2] 0.0001
TAP alertness with audio alert; median reaction time 18 -2.2 ± 1.0 [-2.7 - -1.7] 20 -0.3 ± 0.8 [-0.7 - 0.1] < 0.0001
TAP alertness with audio alert; SD reaction time 18 -1.5 ± 1.3 [-2.1 - -0.8] 20 0.2 ± 0.7 [-0.1 - 0.6] 0.0002
TAP divided attention median reaction time 18 -2.0 ± 1.1 [-2.5 - -1.5] 20 -1.1 ± 0.7 [-1.5 - -0.8] 0.0008
TAP divided attention SD reaction time 18 -1.8 ± 1.0 [-2.3 - -1.3] 20 -0.2 ± 0.9 [-0.7 - 0.2] 0.0001
TAP divided attention omissions 18 -2.7 ± 0.9 [-3.2 - -2.3] 20 -0.2 ± 0.6 [-0.5 - 0.1] < 0.0001
TAP go-no-go median reaction time 18 -1.4 ± 1.9 [-2.4 - -0.5] 20 -0.5 ± 0.6 [-0.8 - -0.2] 0.0052
TAP go-no-go reaction time SD 18 0.0 ± 1.3 [-0.7 - 0.6] 20 2.5 ± 0.8 [2.1 - 2.9] < 0.0001
TAP go-no-go errors 18 -0.3 ± 1.1 [-0.9 - 0.2] 20 0.1 ± 0.7 [-0.2 - 0.5] 0.2482
WCST concepts 20 -1.2 ± 1.1 [-1.7 - -0.7] 20 0.0 ± 1.0 [-0.5 - 0.5] 0.0013
WCST reaction time 20 1.8 ± 3.2 [0.3 - 3.2] 20 0.0 ± 1.0 [-0.5 - 0.5] 0.0133
WCST errors 20 -0.8 ± 1.3 [-1.3 - -0.2] 20 0.0 ± 1.0 [-0.5 - 0.5] 0.0639
WCST perseverations 20 0.9 ± 1.9 [0.0 - 1.7] 20 0.0 ± 1.0 [-0.5 - 0.5] 0.0167
CFT copy 19 -2.2 ± 1.2 [-2.8 - -1.6] 20 0.9 ± 0.4 [0.8 - 1.1] < 0.0001
CFT recall 30 min 19 -1.2 ± 0.9 [-1.7 - -0.8] 20 0.8 ± 0.6 [0.5 - 1.1] < 0.0001
CFT %recall 18 -0.4 ± 1.5 [-1.1 - 0.4] 20 0.6 ± 0.6 [0.4 - 0.9] 0.0040
CFT copy-recall 19 1.0 ± 1.4 [0.3 - 1.6] 19 0.5 ± 0.7 [0.2 - 0.8] 0.0726
NVLTR true positive 20 -1.4 ± 1.7 [-2.1 - -0.6] 19 -0.2 ± 1.1 [-0.7 - 0.4] 0.0076
NVLT false positive 20 -0.6 ± 1.7 [-1.4 - 0.2] 19 -0.7 ± 0.7 [-1.0 - -0.3] 0.4397
Difference t+/f+ NVLT 20 -2.1 ± 0.9 [-2.6 - -1.7] 19 -0.7 ± 0.9 [-1.1 - -0.3] 0.0001
VLT true positive 20 -1.6 ± 1.4 [-2.3 - -1.0] 19 0.2 ± 1.2 [-0.3 - 0.8] 0.0006
VLT false positive 20 -0.2 ± 1.5 [-0.9 - 0.5] 19 -0.2 ± 0.9 [-0.6 - 0.2] 0.7466
Difference t+/f+ VLT 20 -1.5 ± 1.4 [-2.1 - -0.9] 19 -0.1 ± 0.8 [-0.5 - 0.2] 0.0033
LGT city map test 20 -2.1 ± 0.8 [-2.5 - -1.8] 19 0.0 ± 1.0 [-0.5 - 0.5] < 0.0001
WMS logical memory I 20 -1.5 ± 1.5 [-2.2 - -0.8] 20 0.7 ± 1.0 [0.2 - 1.1] 0.0001
WMS logical memory II 20 -1.8 ± 1.2 [-2.3 - -1.2] 20 0.6 ± 0.8 [0.2 - 1.0] < 0.0001
WMS visual pairs I 19 -0.8 ± 1.4 [-1.5 - -0.1] 19 0.4 ± 1.1 [-0.1 - 0.9] 0.0094
WMS visual pairs II 19 -0.8 ± 1.5 [-1.6 - -0.1] 19 0.7 ± 0.5 [0.5 - 1.0] 0.0017
WMS verbal pairs I 19 0.4 ± 1.5 [-0.4 - 1.1] 20 0.7 ± 1.1 [0.2 - 1.2] 0.5741
WMS verbal pairs II 18 -0.9 ± 1.5 [-1.6 - -0.1] 20 0.3 ± 0.9 [-0.2 - 0.7] 0.0179
HAWIE similarities 17 -0.5 ± 1.1 [-1.1 - 0.1] 20 1.5 ± 1.3 [0.9 - 2.0] 0.0001
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“depression”, “anxiety”, “phobic anxiety”,a n d“psychoti-
cism”. However, only for the subscale “depression” were
these differences higher than one standard deviation. As
compared to the control group, depressive mood repre-
sents the main mental problem in patients after DCH
(median [25
th/75
th perc.] z value -3 [-3/-1.2]P vs. -0.02
[-0.4/0.77]C, p < 0.001). Thirteen of 20 patients after
DCH were depressive (compared to none in the control
group). Of our patients, only half were treated with anti-
depressive drugs. No patient underwent psychotherapy.
BDI z values from patients without epilepsy were not sig-
nificantly lower than those of patients with epilepsy (-3
[-3/-2.77]P-1.98 [-3/1.16]C, p = 0.23).
Health-related Quality of Life
In all domains the analysis of the WHOQoL Bref ques-
tionnaire showed results indicative of lower quality of
life in patients compared with the control group (Figure
2). Mean z values for the WHOQoL questionnaire dis-
played a clinically significant impairment of the health-
related QoL. The WHOQoL-Bref subscales and the
overall WHOQoL score were not significantly different
in the stroke patient group with respect to the level of
education (WHOQoL-Brefoverall: Kruskal-Wallis p =
0.16) but they were correlated significantly with the BDI
z values (r = 0.7, p < 0.001). All WHOQoL subscales
and the WHOQoL-Brefoverall score were positively corre-
lated with each cognitive domain.
Discussion
That DCH can be a life-saving treatment option for
complete MCA stroke is no longer a matter of debate
[3,5,9-11,37-39]. However, there are only limited neu-
ropsychological data on patients who underwent decom-
pressive hemicraniectomy after complete MCA
infarction. Only one previous study of 14 patients who
underwent DCH focused on neuropsychological seque-
lae [40]. In contrast to the promising data on survival
for DCH, our findings on impairment of higher cortical
functions after DCH were not at all encouraging: More
than two-thirds of our patients met the criteria for
dementia after the hemispheric stroke. In contrast to
Table 2 Neuropsychological test results (Continued)
5-point test 17 -2.6 ± 0.7 [-2.9 - -2.2] 20 -0.2 ± 1.1 [-0.7 - 0.3] < 0.0001
WMS digit span (forward) 17 -0.1 ± 1.4 [-0.8 - 0.6] 20 0.6 ± 0.9 [0.2 - 1.1] 0.0722
WMS digit span (backwards) 17 -1.1 ± 1.4 [-1.8 - -0.3] 20 -0.2 ± 1.2 [-0.8 - 0.3] 0.0148
Corsi block span (forward) 17 -1.9 ± 1.0 [-2.4 - -1.4] 20 0.0 ± 1.2 [-0.5 - 0.6] 0.0001
Corsi visual span (backwards) 17 -2.5 ± 0.6 [-2.9 - -2.2] 20 -0.4 ± 0.9 [-0.8 - 0.0] < 0.0001
RWF verbal fluency 20 -1.3 ± 0.8 [-1.7 - -1.0] 20 0.3 ± 0.7 [0.0 - 0.6] < 0.0001
RWF semantic verbal fluency with alternations 20 -1.5 ± 0.8 [-1.9 - -1.2] 20 0.5 ± 0.6 [0.2 - 0.8] < 0.0001
AAT mistakes 19 -1.2 ± 1.8 [-2.0 - -0.3] 20 0.1 ± 0.7 [-0.3 - 0.4] 0.0264
Descriptive data for patient group and control group, comparison performed with the Whitney-Mann U-test
Figure 1 Neuropsychological domain mean ± SD z values (all
domains of the patients group are significantly different from
the control group).
Figure 2 Domain mean ± SD z values of quality of life, sleep
quality and mental symptom load (all domains of the patients
group are significantly different from the control group).
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Page 6 of 10Leonhardt et al. [40] who found that mean visuo-spatial
and visuo-constructive capabilities were nearly normal
and self-assessed mood not at all impaired, none of the
cognitive domain z values in our patient group fell
within the normal range. The only results comparable
to ours were for attention and non-verbal memory. The
reason for the discrepancy between our findings and
Leonhardt et al. is that they did not focus on memory
and learning and - after observing the difficulties
patients had with tests for attention and psychomotor
speed -they just eliminated most of the tests for this
domain.
The self-assessment of mood in our patient group
revealed significant impairments. In contrast to Leon-
hardt [8], but congruent with other authors [9,41], we
found increased scores for the BDI, although the major-
ity of the patients had received anti-depressive drugs.
These results can be clearly explained by previous find-
ings on right-sided brain pathology: Right-sided hemi-
spheric lesions impair both verbal and non-verbal
memory and learning [42,43]. In patients who under-
went right-sided surgical pallidotomy, one observed, in
addition to learning deficits for verbal and non-verbal
content, a deterioration of frontal executive and visuo-
constructive functions [44]. Patients with right-sided
fronto-temporal lobe atrophy have problems with spatial
memory [45] and are also prone to develop affective dis-
orders such as depression [46] or problems with the
emotional processing [47-50]. The results in our patients
after massive stroke-induced destruction of the right
hemisphere underline the importance of this side of the
brain for cognition and mood.
In regard to cognitive outcome after DCH, our results
m a yb et o on e g a t i v es i n c e8o fo u rp a t i e n t sw e r eo l d e r
than 60 years, whereas other recent studies included
only patients up to 60 years [11]. Furthermore, the cur-
rent guidelines of the European Stroke Organization
(ESO) recommend a maximum cut-off age of 60 years
for the DCH [51].
The higher age of our study population also explains
the high proportion of patients with an unfavorable
Rankin scale (75% in our study) compared to 43% in
pooled data from the DESTINY, HAMLET and DECI-
MAL trials. Thus, the population analyzed here is cer-
tainly not comparable to the study groups in the above
m e n t i o n e ds t u d i e so nD C H .T h es a m ei st r u ef o rt h e
variance of time from stroke onset to the neuropsycho-
logical tests. Therefore, our data should be interpreted
cautiously with respect to these issues and might not be
valid for a younger population examined within a nar-
rower time interval after the treatment. Our findings are
comparable to another study with a similar rate of unfa-
vorable outcome (73.7%) [7] which also included older
patients. Furthermore, our data on indicators of
activities of daily living (NEADL, BI) may also not be
representative of a younger population. Other studies
which included older patients also found these indica-
tors to be correlated negatively with age [7].
Another limitation of our investigative focus on cogni-
tive deficits is that patients with speech-dominant hemi-
s p h e r i cs t r o k ew e r en o ti n c l u d e d .O u rf i n d i n g sf o rt h e
depression questionnaires, therefore, are not transferable
to patients with DCH over the speech-dominant hemi-
sphere, as it is well known that mood disturbances
appear more often in patients with right-sided stroke
than in those with left-sided cerebral ischemia [43,47].
Strategically unfavorable localizations of small right-
sided strokes, i.e. in the frontal projections of the corpus
callosum, can cause major depression [49]. The same is
true for cognitive functions; neuropsychological investi-
gations of patients after neurosurgical interventional
treatment of Parkinson’s disease have shown the impor-
tance of the right brain for cognitive functions [44,52].
In regard to both mood and cognition, our findings
may significantly differ from patients with left-sided
MCA infarctions and DCH. Since this study focused on
cognitive functioning, reliable results were dependent on
the patient’s understanding of the test rules. The degree
of comprehension is extremely difficult to quantify in
partially aphasic patients, and there is no general rule as
to how to correct the cognitive results for the individual
type of aphasia. Therefore, we decided to exclude
patients with speech-dominant hemispheric infarctions
rather than misinterpreting their cognitive test results.
As in other studies on DCH, most of our patients
were able to walk after DCH and had regained some
independence, despite the persisting physical handicaps
[11]. Physical impairment is, however, just one element
which affects human well-being; in our patient group,
the quality of life was significantly lower than in healthy
control patients, which matches the findings reported by
other groups [4,53,54]. Not surprisingly, in our patients,
hrQoL was significantly correlated with the Beck’s
depression inventory. This underlines the necessity to
diagnose and to treat post-stroke depression early and
effectively in such patients. Depression is often a cause
of cognitive disturbances, and vice versa. Our data do
not allow us to safely quantify the influence of depres-
sive pseudo-dementia on the test results. However, since
cognition and mood interact closely, it is very difficult
or perhaps impossible to differentiate their mutual influ-
ences. The lack of a significant correlation between the
BDI and cognitive functioning, however, indicates that
depression was not the primary factor affecting cognitive
performance in DCH patients. In addition to the lack of
a significant correlation of cognitive scores with the
BDI, our patients also showed abnormal results for ver-
bal learning and visual constructive tests. These domains
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Page 7 of 10are usually spared in depressive pseudo-dementia
[55,56].
The presence of symptomatic epilepsy should have an
influence on cognitive functioning as well as mood [57].
Particularly right-sided brain pathology should predis-
pose patients with epilepsy for depression [58]. It is
most likely that the sample size of our study population
was too small to reproduce these effects.
All told, the findings demonstrate that the probable out-
come after DCH of the non-speech dominant hemispheric
infarction includes significant cognitive deficits along with
a physical handicap and impaired mood, and conse-
quently, a diminished quality of life. The prospect of living
with depression combined with severe physical and cogni-
tive handicaps may be inacceptable for many patients; for
others, however, it might be the better option compared
to 70-80% mortality with a conservative treatment [59].
A significant limitation of this study in regard to the
discussion of post-hoc patient agreement is the lack of
information on long-term cognitive deficits in patients
who survived a conservative treatment. It is possible
that neurological and cognitive sequelae in these
patients are higher than in those who had been operated
on due to the untreated swelling of the ischemic brain
regions. To our knowledge no such data are available.
The group of the operated patients who stated that if
they had to decide again, they would not have opted for
DCH did not differ significantly in their neuropsycholo-
gical test results, and also did not display lower quality
of life scores as compared to the patients who stated
that they would again opt for DCH. However, the for-
m e rp a t i e n tg r o u ps u f f e r e df rom significantly higher
scores for depressive mood (p = 0.039) than the latter.
More than half of our patients were treated with anti-
depressive drugs. It could be hypothesized that the
patients whose post-hoc assessment of DCH was nega-
tive just needed a better anti-depressive treatment, espe-
cially since the agreement rates in our patient group
were considerably lower than in other trials (e.g. [5]).
Our data can neither confirm nor reject this hypothesis.
The fact that there was no difference in BDI score
between the patients who were administered anti-
depressive drugs and those who were not might argue
against this idea. However, all reported rates of retro-
spective agreement with DCH could be severely biased
by the interview situation. The patients were interviewed
b yap e r s o nw h ow a si n v o l v e di nt h e i rs t r o k et r e a t m e n t
and thus in the life-saving process, which may have
inhibited them from answering honestly, at the risk of
appearing ungrateful.
Conclusion
The fact that in the majority of patients a significant
cognitive decline is to be expected should not lead to a
general rejection of DCH as a treatment option. The
problem for the treating physician is to ascertain
whether the patient is willing to risk death with conser-
vative treatment or survive to a life of coping with
impaired neurocognitive functions, probable depression
and diminished quality of life. Ideally, this decision
should be made by the patients themselves, which is too
often not possible.
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